Search
Memorial Sloan Kettering Cancer Center announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient medical facility to be known as The David H. Koch Center for Cancer Care. The new center will provide the most advanced cancer treatments in a dynamic space designed with the needs of patients firmly in mind.
During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.
Learn how a bone marrow transplant saved the life of a child with a rare blood disease.
Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.
In patients with resected pancreatic ductal adenocarcinoma, alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency genes were associated with favorable prognoses.
A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
A Q&A with MSK Urologic Surgeon Richard Matulewicz, MD, MSCI, MS.
Hear from Memorial Sloan Kettering breast surgical oncologist Tracy-Ann Moo about her experience as a woman of color in medicine.
Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.
Learn about seven nursing staff members were honored with a Robbins Family Award for Nursing Excellence.